Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population
3.2.1.2 Technological advancements in facial injectables
3.2.1.3 Increasing awareness and acceptance of aesthetic treatments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 Risk of adverse reactions
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Collagen
5.3 Poly methyl methacrylate (PMMA) microspheres
5.4 Hyaluronic acid (HA)
5.5 Botulinum toxin
5.6 Calcium hydroxylapatite (CaHA)
5.7 Poly-L-lactic acid (PLLA)
5.8 Fat injection
5.9 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Wrinkle reduction
6.3 Facial line correction
6.4 Lip augmentation
6.5 Face lift
6.6 Acne scar treatment
6.7 Lipoatrophy treatment
6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Medical spas
7.3 Dermatology clinics
7.4 Hospitals
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AbbVie Inc.
9.2 Anika Therapeutics, Inc.
9.3 APAX Partners
9.4 Bioplus Co., Ltd.
9.5 Croma-Pharma GmbH
9.6 Galderma SA
9.7 Ipsen Pharma
9.8 Lutronic Corporation
9.9 Medytox
9.10 Merz Pharma
9.11 Prollenium Medical Technologies
9.12 Revance Therapeutics, Inc.
9.13 Sinclair
9.14 Suneva Medical
9.15 Teoxane
